NO831011L - Diagnostisk preparat. - Google Patents

Diagnostisk preparat.

Info

Publication number
NO831011L
NO831011L NO831011A NO831011A NO831011L NO 831011 L NO831011 L NO 831011L NO 831011 A NO831011 A NO 831011A NO 831011 A NO831011 A NO 831011A NO 831011 L NO831011 L NO 831011L
Authority
NO
Norway
Prior art keywords
structural element
macromolecular carrier
preparation according
bacteria
residue
Prior art date
Application number
NO831011A
Other languages
English (en)
Norwegian (no)
Inventor
Per Anders Maardh
Sigfrid Svensson
Original Assignee
Svenska Sockerfabriks Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Svenska Sockerfabriks Ab filed Critical Svenska Sockerfabriks Ab
Publication of NO831011L publication Critical patent/NO831011L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO831011A 1982-03-22 1983-03-22 Diagnostisk preparat. NO831011L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8201815 1982-03-22

Publications (1)

Publication Number Publication Date
NO831011L true NO831011L (no) 1983-09-23

Family

ID=20346330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831011A NO831011L (no) 1982-03-22 1983-03-22 Diagnostisk preparat.

Country Status (6)

Country Link
EP (1) EP0089939A1 (da)
JP (1) JPS58174327A (da)
AU (1) AU561066B2 (da)
DK (1) DK130983A (da)
FI (1) FI830959L (da)
NO (1) NO831011L (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301609D0 (sv) * 1983-03-23 1983-03-23 Svenska Sockerfabriks Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
DE3402739A1 (de) * 1984-01-27 1985-08-01 Boehringer Ingelheim Diagnostika GmbH, 8046 Garching Antikoerper gegen den glycanstrang des peptidoglycans, verfahren und reagenzien zu ihrer herstellung und methoden zu ihrer quantitativen bestimmung
CH660557A5 (fr) * 1984-10-26 1987-05-15 Nestle Sa Composition anti-bacterienne et procede de preparation de ses constituants actifs.
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
EP0209493A3 (en) * 1985-07-16 1988-05-04 Ciba-Geigy Ag Prophylaxis and treatment of whooping cough
EP0285357A3 (en) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Control of retroviruses
ES2024641B3 (es) * 1987-05-20 1992-03-01 Kk Ueno Seiyaku Oyo Kenkyujo Preservativo.
DE3718181A1 (de) * 1987-05-29 1988-12-15 Hoechst Ag Glycosylierte aminosaeuren und peptide
DE68918189T2 (de) 1988-06-29 1995-01-12 Univ Rockefeller Neisseria-Vakzine.
ATE158080T1 (de) * 1991-10-01 1997-09-15 Biostar Inc Hochempfindlicher optischer immunoassay durch gebrauch von enzymmarkierten reagenz
EP0601417A3 (de) * 1992-12-11 1998-07-01 Hoechst Aktiengesellschaft Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
US6406894B1 (en) 1992-12-11 2002-06-18 Glycorex Ab Process for preparing polyvalent and physiologically degradable carbohydrate-containing polymers by enzymatic glycosylation reactions and the use thereof for preparing carbohydrate building blocks
DE4431280A1 (de) 1994-09-02 1996-03-07 Hoechst Ag Verfahren zur Isolierung und Reinigung von nukleotidaktivierten Zuckern aus biologischen Quellen
EP1301797A2 (en) * 2000-07-17 2003-04-16 Hansa Medical AB Antimicrobial agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0058665B1 (en) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
CA1203532A (en) * 1980-07-10 1986-04-22 Chembiomed Ltd. Synthesis of tumor antigenic determinant
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
DE3106815A1 (de) * 1981-02-24 1982-09-09 Behringwerke Ag, 3550 Marburg "chemische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als antigene oder immunadsorbentien"

Also Published As

Publication number Publication date
AU1262583A (en) 1983-09-29
DK130983A (da) 1983-09-23
DK130983D0 (da) 1983-03-22
EP0089939A1 (en) 1983-09-28
FI830959A0 (fi) 1983-03-22
FI830959A7 (fi) 1983-09-23
FI830959L (fi) 1983-09-23
JPS58174327A (ja) 1983-10-13
AU561066B2 (en) 1987-04-30

Similar Documents

Publication Publication Date Title
US4851338A (en) Method for diagnosing the presence of bacteria
FI71432B (fi) Diagnostiska kompositioner och deras anvaendning i samband medbakterieinfektioner
Gupta et al. Pili and lipopolysaccharide of Pseudomonas aeruginosa bind to the glycolipid asialo GM1
NO831011L (no) Diagnostisk preparat.
CZ232593A3 (en) Pharmaceutical preparation for preventing and/or therapy of pathological states
Arp et al. Piliation, hemagglutination, motility, and generation time of Escherichia coli that are virulent or avirulent for turkeys
JPH09511220A (ja) バクテリアによって誘発される炎症性疾患の治療
JPH0450531B2 (da)
Bjornson et al. Bacteroidaceae in thromboembolic disease: effects of cell wall components on blood coagulation in vivo and in vitro
JP2645665B2 (ja) ヒトモノクローナル抗体
JPH04502153A (ja) マイコプラズマ　ニューモニエ及びマイコプラズマホミヌスのスルファチドへの接着
FI59024B (fi) Foerfarande foer framstaellning och rening av en antigen till c-gruppen hoerande meningokockpolysackarid som har hoeg molekylvikt och aer aktiv mot av c-gruppens meningokocker orsakad meningit
EP0089940A1 (en) Compositions for therapeutic or diagnostic use containing oligosaccharides
Kabir et al. Neuraminidase production by Vibrio cholerae O1 and other diarrheagenic bacteria
WO1986005789A1 (en) Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use
PL156487B1 (pl) Sposób prowadzenia hodowli Treponema hyodysenteriae PL PL PL
CN110237251B (zh) 一种复合特异性卵黄抗体口腔喷雾剂及其制备方法
CN110907372A (zh) 包含白芨提取物的牙膏抗炎性能体外评价模型和方法
IE44448B1 (en) Gonococcal pili processes for the preparation thereof and the use thereof
Rivier et al. Inhibitors of the adhesiveness of enteropathogenic E. coli
EP0149581B1 (fr) Nouvelles compositions contenant des oligo-muramylpeptides et leur application, notamment pour l'activation des macrophages
Grandics Pyrogens in parenteral pharmaceuticals
Kloryga Pathogenicity of five rough mutants of Escherichia coli isolated from broilers
JPH088873B2 (ja) ヒト癌壊死因子の製造法
Repo et al. Antibody-and complement-dependent cell injury assayed by 51Cr release from human peripheral blood mononuclear cells pretreated with lipopolysaccharide